Nuvaxovid

NVX-CoV2373 · Novavax

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Nuvaxovid, covering 2021-11-17 to 2026-08-07. Get the full timeline:

Most recent: EMA Authorised: Nuvaxovid (SARS CoV-2 (Original) recombinant spike protein;SARS-CoV-2 (Omicron XBB.1.5) recombinant spike protein) — Sanofi Winthrop Industrie

See pricing